Twitter

Archive for February 21st, 2012


What are the side effects of prostate cancer treatments?

If you are about to undergo treatment for prostate cancer then you will most likely be concerned about the potential side effects. Choosing treatments like brachytherapy over surgery could minimise the risk of developing troubling side effects like incontinence. In the following short film three men discuss the side effects they had from surgery, brachytherapy, and hormone therapy. Learn how they coped and what side effects troubled them the most here.

Read More...

Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial

Condition :   Diffuse Large B-Cell Lymphoma Intervention :   Biological: rituximab Sponsor :   Celltrion Not yet recruiting – verified February 2012

Read More...

Nilotinib in PH+, BCR-, ABL+ CML Patients

Condition :   Chronic Myeloid Leukemia Intervention :   Drug: Nilotinib Sponsor :   Gruppo Italiano Malattie EMatologiche dell’Adulto Not yet recruiting – verified February 2012

Read More...

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma

Condition :   Lymphoma, Non-Hodgkin Intervention :   Drug: IMGN529 Sponsor :   ImmunoGen, Inc. Recruiting – verified February 2012

Read More...

Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML

Condition :   Acute Myeloid Leukemia Intervention :   Drug: clofarabine, cytarabine, idarubicin Sponsors :   Hannover Medical School;   Hannover Clinical Trial Center GmbH;   Genzyme Recruiting – verified February 2012

Read More...

Brentuximab Plus AVD in Limited-stage Hodgkin Lymphoma

Condition :   Hodgkin Lymphoma Interventions :   Drug: Brentuximab Vedotin;   Drug: Adriamycin, vinblastine, and dacarbazine Sponsor :   Massachusetts General Hospital Not yet recruiting – verified February 2012

Read More...

Patient Satisfaction in Cutaneous Surgery

Condition :   Skin Cancer Intervention :   Sponsor :   Northwestern University Recruiting – verified February 2012

Read More...

CP-751,871 Treatment For Patients With Multiple Myeloma

Condition :   Multiple Myeloma Intervention :   Drug: CP-751,871 Sponsor :   Pfizer Completed – verified February 2012

Read More...

PATH Partnering to Achieve Tobacco-free Health

Condition :   Smoking Cessation Interventions :   Other: Acceptance & Commitment Therapy (ACT);   Other: Cognitive Behavioral Therapy (CBT) Sponsor :   Fred Hutchinson Cancer Research Center Recruiting – verified February 2012

Read More...

Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents

Condition :   Brain Tumor Intervention :   Drug: Irinotecan combination chemotherapy Sponsor :   Seoul National University Hospital Recruiting – verified February 2012

Read More...